pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
89
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
NES-100
Cancer Pain
Virpax Pharmaceuticals Inc
0
catalysts
Preclinical
NTM-004
Pain
Neumentum Inc
0
catalysts
Preclinical
NTM-005
Pain
Neumentum Inc
0
catalysts
Phase 3
OPL-015
Pain
Overseas Pharmaceuticals Ltd
← prev
page 3 of 3
next →
131
Pain
89
Neurology
1
0
catalysts
Phase 1
PF614-MPAR
Pain
$ENSC
Ensysce Biosciences, Inc.
0
catalysts
Phase 1
SBS-1000
Pain
Sparian Biosciences Inc
0
catalysts
Preclinical
SGN-624
Pain
SGN Nanopharma Inc
0
catalysts
Preclinical
TD-501
Pain
OB Pharmaceuticals
0
catalysts
Preclinical
TD-567
Epilepsy
OB Pharmaceuticals
0
catalysts
Phase 2
TRN-261
Pain
Tris Pharma Inc
0
catalysts
Marketed
aspirin
Vazalore (aspirin [INN])
Pain
$ASBP
Aspire Biopharma Holdings, Inc.
0
catalysts
Marketed
bupivacaine hydrochloride
Bupivacaine Hydrochloride (bupivacaine hydrochloride)
Oral Mucositis
Sodium channel protein type 4 subunit alpha
OncoZenge AB
0
catalysts
Marketed
cannabidiol
Epidiolex (cannabidiol)
Infantile Spasm (West Syndrome)
Cannabinoid receptor 1
$JAZZ
Jazz Pharmaceuticals plc
0
catalysts
Marketed
carisoprodol
Carisoprodol (carisoprodol)
Myalgia (Muscle Pain)
Nostrum Laboratories LLC
0
catalysts
Phase 3
cebranopadol
Pain
Nociceptin receptor
Opioid receptors; mu/kappa/delta
Tris Pharma Inc
0
catalysts
Marketed
chlorzoxazone
Chlorzoxazone (chlorzoxazone [INN])
Myalgia (Muscle Pain)
Belcher Pharmaceuticals LLC
0
catalysts
Marketed
diclofenac potassium
Cataflam (diclofenac potassium)
Primary Dysmenorrhea
Amici Pharmaceuticals LLC
0
catalysts
Marketed
diflunisal
Diflunisal (diflunisal)
Osteoarthritis Pain
Heritage Pharmaceuticals Inc
0
catalysts
Marketed
dyclonine
Dyclopro (dyclonine [INN])
Pharyngitis
Septodont Inc
0
catalysts
Marketed
etodolac
Etodolac (etodolac)
Osteoarthritis Pain
Bayshore Pharmaceuticals LLC
0
catalysts
Marketed
fenoprofen calcium
Fenotrho Sterling (fenoprofen calcium)
Osteoarthritis Pain
Sterling Knight Pharmaceutical
0
catalysts
Marketed
ketoprofen ER
Ketoprofen (ketoprofen)
Osteoarthritis Pain
Mylan Pharmaceuticals Inc
0
catalysts
Phase 3
linzagolix choline
Pain
Gonadotropin-releasing hormone receptor
Kissei Pharmaceutical Co Ltd
0
catalysts
Marketed
meclofenamate sodium
Meclofenamate Sodium (meclofenamate sodium)
Acute and Sub-Acute Bursitis
Mylan Pharmaceuticals Inc
0
catalysts
Marketed
meloxicam
Qamzova (meloxicam)
Post-Operative Pain
Nanjing Delova Biotech Co Ltd
0
catalysts
Marketed
metaxalone
Metaxalone Corepharma (metaxalone)
Myalgia (Muscle Pain)
CorePharma LLC
0
catalysts
Marketed
methocarbamol
Methocarbamol (methocarbamol [INN])
Muscle Spasm
Beximco Pharmaceuticals USA Inc
0
catalysts
Phase 1
oxymorphone ER
oxymorphone [INN]
Pain
Avecho Biotechnology Ltd
0
catalysts
Marketed
ziconotide
Prialt (ziconotide)
Pain
Esteve Pharmaceuticals SA
0
catalysts
